ProCE Banner Activity

Risk Stratification and MDS Management: A Nursing Perspective

Clinical Thought

An expert summary of risk stratification and management of lower- and higher-risk MDS, including a discussion of emerging therapies.

Released: August 22, 2022

Expiration: August 21, 2023

No longer available for credit.



Sara Tinsley-Vance

Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner and Researcher
Malignant Hematology
Moffitt Cancer Center
Tampa, Florida


This program is supported by educational grants from Merck Sharp & Dohme Corp; Regeneron Pharmaceuticals, Inc. and Sanofi; and Taiho Oncology, Inc.

Provided by

ProCE Banner

Target Audience

Oncology NPs, PAs, and RNs


Sara Tinsley-Vance, PhD, MSN, APRN-BC, AOCN: consultant: AbbVie, Bristol-Myers Squibb, CTI BioPharma, Incyte, Taiho Oncology; fees for non-CME/CE services: Astellas, Bristol-Myers Squibb, CTI BioPharma, Incyte.



Additional Information

Program Medium

This program has been made available online.